⌘K

Login Start Free

Home/Filings/4/0001493152-22-021328

4//SEC Filing

Ritter Ira E. 4

Accession 0001493152-22-021328

CIK 0001460702other

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 4:16 PM ET

Size

16.5 KB

Accession

0001493152-22-021328

Insider Transaction Report

Form 4

Period: 2022-07-11

Qualigen Therapeutics, Inc.QLGN

DirectorExec. Chairman, CSO

Transactions

Award
Stock Option (Right to Buy)
2022-07-11+40,000→ 40,000 total
Exercise: $0.51Exp: 2032-07-11→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.

Documents

2 files

Issuer

Qualigen Therapeutics, Inc.

CIK 0001460702

Entity typeother

Related Parties

1

filerCIK 0001631674

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 4:16 PM ET
Size: 16.5 KB

View on SEC.gov